Center for Multiple Myeloma
Multiple Myeloma is the second most common blood cancer disease in adults. The risk of developing the disease increases with increasing age. The median age of onset is 70 years. Multiple myeloma significantly impairs quality of life through bone pain, organ dysfunction, and chronic fatigue. Treatment therefore requires interdisciplinary collaboration. Patients today have the chance to live well with the disease.
Central outpatient hotline at the Interdisciplinary Tumor Center ITZ: Telephone: +49 (0)761 270-35555
Map
Registration for appointments at the Center for Multiple Myeloma: Telephone: +49 (0)761 270-71580
Consultation hour for multiple myeloma / plasmacytoma:
Prof. Dr. Monika Engelhardt: Telephone: +49 (0)761 270-32460
Interdisciplinary Tumor Center
Hugstetter Str. 53
79106 Freiburg
We strive to provide a directed diagnosis and therapy, which we discuss in our multiple myeloma board with internists, radiologists, orthopedists, radiotherapists, pathologists, biologists, and other specialists. The standard methods for treating multiple myeloma are chemotherapy, genetic therapy, and radiation therapy. For patients of up to around 70 years, chemotherapy is usually followed by a stem cell transplantation (in German). Our treatment endeavors to achieve a good balance between response to therapy and maintenance of quality of life. Very many of our patients experience a complete remission that lasts for years. A tightly knit regimen of follow-up examinations after therapy is absolutely essential.
Trials
Around one-third of our patients participate in trials on the development of new therapies and maintenance of quality of life.
Find out more (in German)
Prof. Dr. Monika Engelhardt
Director
Telephone: +49 (0)761 270-32460
monika.engelhardt@uniklinik-freiburg.de
Dr. Cornelius Miething
Coordinator
Telefon +49(0)761 270-71830
cornelius.miething@uniklinik-freiburg.de
Ph.D Nikolaos Karantzelis
Coordinator
nikolaos.karantzelis@uniklinik-freiburg.de
On November 26, 2022, the 9th Freiburg Patient and Family Forum took place under the direction of Prof. Dr. Monika Engelhardt, reporting on current developments, findings and therapies in the treatment of hematological and oncological tumor diseases. The film offers an interesting insight into the successful day.
When: Monday, 3:30 p.m.
Where: Interdisciplinary Tumor Center ITZ, R.00.153
Boardleitung: Prof. Dr. Monika Engelhardt
0761 270 32460
monika.engelhardt@uniklinik-freiburg.de
Registration deadline: Monday, 10 a.m.
2 continuing education credits from the Baden-Württemberg State Medical Association